Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Recruiting now

Conditions studied: Parkinson's Disease

In brief

The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated. Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated.

Key facts

Study ID

NCT02071134

Run by

Boston Scientific Corporation

People needed

1500

Starts

2014-03-04

Expected to finish

2038-12-01

Last updated by the study team

2026-07-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Inland Northwest Research — Spokane, Washington, United States (enrolling)
• Universitätsklinikum Campus Kiel — Kiel, Germany (enrolling)
• Evergreen Health — Kirkland, Washington, United States (enrolling)
• University of Washington Medical Center — Seattle, Washington, United States (enrolling)
• University Berlin, Charite Virchow Standort, Wedding — Berlin, Germany (enrolling)
• Universitätsklinik Eppendorf — Hamburg, Germany (enrolling)
• St. Mary's Hospital and Medical Center — Grand Junction, Colorado, United States (enrolling)
• Cedars Sinai Medical Center — Los Angeles, California, United States (enrolling)
• University of Florida Shands Hospital — Gainesville, Florida, United States (enrolling)
• Rush University Medical Center — Chicago, Illinois, United States (enrolling)
• Fundacion Ineco-Research Facility — Buenos Aires, Argentina (enrolling)
• A.o. LKH Univ.-Kliniken Innsbruck — Innsbruck, Austria (enrolling)
• University of Miami Hospital — Miami, Florida, United States (enrolling)
• Universitätsklinikum Düsseldorf — Düsseldorf, Germany (enrolling)
• Northwell Health Neuroscience Institute — Great Neck, New York, United States (enrolling)
• University at Buffalo — Williamsville, New York, United States (enrolling)
• Wake Forest University School of Medicine — Winston-Salem, North Carolina, United States (enrolling)
• University of South Florida — Tampa, Florida, United States (enrolling)
• Ohio State University — Columbus, Ohio, United States (enrolling)
• St. Luke Regional Medical Center — Boise, Idaho, United States (enrolling)
• Houston Methodist Research Institute — Houston, Texas, United States (enrolling)
• University of Texas Health Medical Arts and Research Center — San Antonio, Texas, United States (enrolling)
• Texas Institute for Neurological Disorders — Sherman, Texas, United States (enrolling)
• University of Colorado — Aurora, Colorado, United States (enrolling)
• Universitaetsklinikum Giessen und Marburg GmbH — Marburg, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.